Asklepios BioPharmaceutical, Inc.

Biotechnology company · Durham, North Carolina, United States

Asklepios BioPharmaceutical, Inc. is a biotechnology company headquartered in Durham, North Carolina, United States. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $3.4 million in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $200 million sold in a notice filed in 2019.

Profile compiled from public records. Is this your company? Request a correction or update

Asklepios BioPharmaceutical at a glance

Typebiotechnology company

HeadquartersDurham, North Carolina, United States

SEC CIK1352189

What does Asklepios BioPharmaceutical do?

US government research funding

4 SBIR/STTR small-business research awards from US health agencies, $3.4 million in total (2005 to 2014).

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $199.7 million sold (2019).

Frequently asked questions about Asklepios BioPharmaceutical

Where is Asklepios BioPharmaceutical headquartered?

Asklepios BioPharmaceutical, Inc. is headquartered in Durham, North Carolina, United States.

What does Asklepios BioPharmaceutical do?

Asklepios BioPharmaceutical, Inc. is a biotechnology company.

Similar companies

Humacyte, Inc.Durham, North Carolina, United States
Precision Biosciences IncDurham, North Carolina, United States
Xilis, Inc.Durham, North Carolina, United States
inSoma Bio, Inc.Durham, North Carolina, United States
Atsena Therapeutics, Inc.Durham, North Carolina, United States
Scion Neurostim, Inc.Durham, North Carolina, United States
Sapere Bio, Inc.Durham, North Carolina, United States
BioAesthetics CorpDurham, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences